Letter by McCaw et al Regarding Article, "The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease".

Details

Language :

English

ISSN :

00097322

Volume :

143

Issue :

1

Database :

Complementary Index

Journal :

Circulation

Publication Type :

Academic Journal

Accession number :

148421299

Full Text :

https://doi.org/10.1161/CIRCULATIONAHA.120.050723